Catalyst Pharmaceuticals Shares Outstanding 2006-2020 | CPRX

Catalyst Pharmaceuticals shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Catalyst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 106
2018 103
2017 86
2016 83
2015 81
2014 64
2013 45
2012 30
2011 22
2010 19
2009 15
2008 13
2007 13
2006 8
2005 6
Catalyst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 106
2020-06-30 107
2020-03-31 107
2019-12-31 106
2019-09-30 107
2019-06-30 106
2019-03-31 103
2018-12-31 103
2018-09-30 103
2018-06-30 103
2018-03-31 103
2017-12-31 86
2017-09-30 85
2017-06-30 84
2017-03-31 83
2016-12-31 83
2016-09-30 83
2016-06-30 83
2016-03-31 83
2015-12-31 81
2015-09-30 82
2015-06-30 82
2015-03-31 76
2014-12-31 64
2014-09-30 67
2014-06-30 66
2014-03-31 54
2013-12-31 45
2013-09-30 45
2013-06-30 41
2013-03-31 41
2012-12-31 30
2012-09-30 32
2012-06-30 27
2012-03-31 25
2011-12-31 22
2011-09-30 22
2011-06-30 22
2011-03-31 20
2010-12-31 19
2010-09-30 19
2010-06-30 18
2010-03-31 18
2009-12-31 15
2009-09-30 14
2009-06-30 14
2009-03-31 14
2008-12-31 13
2008-09-30 13
2008-06-30 13
2008-03-31 13
2007-12-31 13
2007-09-30 13
2007-06-30 13
2007-03-31 13
2006-12-31 8
2006-09-30 7
2006-06-30 7
2006-03-31 7
2005-09-30 7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.366B $0.102B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.222B 37.84
Takeda Pharmaceutical (TAK) Japan $55.079B 10.10
Astellas Pharma (ALPMY) Japan $29.863B 18.44
Eisai (ESALY) Japan $20.018B 22.20
Catalent (CTLT) United States $17.797B 47.09
Grifols, S.A (GRFS) Spain $10.973B 12.77
Jazz Pharmaceuticals (JAZZ) Ireland $9.280B 15.50
Neurocrine Biosciences (NBIX) United States $8.758B 20.31
Ionis Pharmaceuticals (IONS) United States $7.435B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.427B 0.00
United Therapeutics (UTHR) United States $7.320B 14.22
Arrowhead Pharmaceuticals (ARWR) United States $7.162B 0.00
IPSEN SA ADR (IPSEY) France $7.097B 0.00
Orion OYJ (ORINY) Finland $5.794B 20.11
Evotec AG (EVTCY) Germany $5.779B 390.28
Turning Point Therapeutics (TPTX) United States $5.483B 0.00
Sage Therapeutics (SAGE) United States $4.494B 0.00
PTC Therapeutics (PTCT) United States $4.229B 0.00
Nektar Therapeutics (NKTR) United States $4.064B 0.00
ChemoCentryx (CCXI) United States $3.985B 0.00
Tilray (TLRY) Canada $3.715B 0.00
Hypermarcas (HYPMY) Brazil $3.546B 13.99
Cronos Group (CRON) Canada $3.415B 0.00
Revolution Medicines (RVMD) United States $3.339B 0.00
FibroGen (FGEN) United States $3.265B 0.00
Pacira BioSciences (PCRX) United States $3.035B 51.26
Corcept Therapeutics (CORT) United States $2.880B 28.88
Taro Pharmaceutical Industries (TARO) Israel $2.851B 17.66
Xencor (XNCR) United States $2.602B 0.00
USANA Health Sciences (USNA) United States $2.114B 17.30
AlloVir (ALVR) United States $1.987B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.979B 0.00
Sundial Growers (SNDL) Canada $1.884B 0.00
ImmunoGen (IMGN) United States $1.788B 0.00
Translate Bio (TBIO) United States $1.672B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.667B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.627B 12.80
Organogenesis Holdings (ORGO) United States $1.626B 0.00
Endo (ENDP) Ireland $1.611B 2.44
Heron Therapeutics (HRTX) United States $1.599B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.484B 9.52
Ocular Therapeutix (OCUL) United States $1.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.251B 0.00
Indivior (INVVY) United States $1.239B 0.00
Zogenix (ZGNX) United States $1.156B 0.00
Aclaris Therapeutics (ACRS) United States $1.104B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.038B 0.00
Trillium Therapeutics (TRIL) Canada $1.033B 0.00
Radius Health (RDUS) United States $1.007B 0.00
Vectura Group (VEGPF) United Kingdom $0.991B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aerie Pharmaceuticals (AERI) United States $0.880B 0.00
Karyopharm Therapeutics (KPTI) United States $0.868B 0.00
Esperion Therapeutics (ESPR) United States $0.811B 0.00
Collegium Pharmaceutical (COLL) United States $0.782B 29.59
Chinook Therapeutics (KDNY) United States $0.730B 0.00
VAXART, INC (VXRT) United States $0.709B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.686B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.653B 0.00
Ardelyx (ARDX) United States $0.602B 0.00
Jounce Therapeutics (JNCE) United States $0.572B 0.00
Flexion Therapeutics (FLXN) United States $0.564B 0.00
Molecular Templates (MTEM) United States $0.554B 0.00
KalVista Pharmaceuticals (KALV) United States $0.554B 0.00
Akebia Therapeutics (AKBA) United States $0.523B 0.00
Siga Technologies (SIGA) United States $0.515B 8.53
Rafael Holdings (RFL) United States $0.505B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.497B 0.00
Altimmune (ALT) United States $0.481B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.480B 0.00
Acutus Medical (AFIB) United States $0.473B 0.00
Summit Therapeutics (SMMT) United States $0.468B 0.00
PROFOUND MEDICL (PROF) Canada $0.451B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.450B 0.00
Harpoon Therapeutics (HARP) United States $0.448B 0.00
AVITA Medical (RCEL) United States $0.426B 0.00
DURECT (DRRX) United States $0.417B 0.00
MEI Pharma (MEIP) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.411B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.351B 22.58
VYNE Therapeutics (VYNE) United States $0.343B 0.00
Redhill Biopharma (RDHL) Israel $0.326B 0.00
Alpine Immune Sciences (ALPN) United States $0.308B 0.00
CASI Pharmaceuticals (CASI) United States $0.281B 0.00
Lannett Co Inc (LCI) United States $0.255B 8.57
Xeris Pharmaceuticals (XERS) United States $0.237B 0.00
CTI BioPharma (CTIC) United States $0.224B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.223B 0.00
Novan (NOVN) United States $0.219B 0.00
IMV INC (IMV) Canada $0.215B 0.00
Oncternal Therapeutics (ONCT) United States $0.211B 0.00
Onconova Therapeutics (ONTX) United States $0.211B 0.00
Concert Pharmaceuticals (CNCE) United States $0.200B 0.00
Nutriband (NTRB) United States $0.197B 0.00
Calithera Biosciences (CALA) United States $0.191B 0.00
KemPharm (KMPH) United States $0.189B 0.00
Jaguar Animal Health (JAGX) United States $0.189B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Iterum Therapeutics (ITRM) Ireland $0.183B 0.00
Taiwan Liposome (TLC) Taiwan $0.183B 0.00
Heat Biologics (HTBX) United States $0.175B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.173B 0.00
Infinity Pharmaceuticals (INFI) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.171B 0.00
Qilian Holding Group (QLI) China $0.166B 0.00
GlycoMimetics (GLYC) United States $0.159B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.157B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.157B 0.00
Aziyo Biologics (AZYO) United States $0.150B 0.00
Aquestive Therapeutics (AQST) United States $0.148B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.147B 0.00
IsoRay (ISR) United States $0.145B 0.00
Genocea Biosciences (GNCA) United States $0.144B 0.00
MediWound (MDWD) Israel $0.137B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.128B 0.00
Otonomy (OTIC) United States $0.121B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.119B 0.00
Lipocine (LPCN) United States $0.117B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.109B 0.00
ProPhase Labs (PRPH) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.100B 0.00
ElectroCore (ECOR) United States $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
Natural Alternatives (NAII) United States $0.091B 24.76
SCYNEXIS (SCYX) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.087B 0.00
Baudax Bio (BXRX) United States $0.086B 0.00
AgeX Therapeutics (AGE) United States $0.084B 0.00
AIM ImmunoTech (AIM) United States $0.083B 0.00
Sigyn Therapeutics (SIGY) United States $0.083B 0.00
Brickell Biotech (BBI) United States $0.078B 0.00
PolarityTE (PTE) United States $0.078B 0.00
Recro Pharma (REPH) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.075B 0.00
India Globalization Capital (IGC) United States $0.074B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.062B 0.00
CV Sciences (CVSI) United States $0.060B 0.00
Inhibikase Therapeutics (IKT) United States $0.060B 0.00
Plus Therapeutics (PSTV) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
Regulus Therapeutics (RGLS) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 23.96
Mannatech (MTEX) United States $0.039B 5.72
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.038B 0.00
RXi Pharmaceuticals (PHIO) United States $0.036B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Cyanotech (CYAN) United States $0.022B 18.20
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
JanOne (JAN) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Xenetic Biosciences (XBIO) United States $0.013B 0.00
SHINECO INC (TYHT) China $0.012B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00